Advanced Filters
noise

Elche, Alicante, Spain Clinical Trials

A listing of Elche, Alicante, Spain clinical trials actively recruiting patients volunteers.

Found 51 clinical trials
M Miguel Leon Arellano

Long-term Enlarged Survival After an Enhanced Recovery Protocol (LESAS).

The main objective of this study is to analyze the impact on three years survival of an enhanced recovery program (PRI) after radical surgery for colorectal cancer. As secondary objectives, we propose to analyze the weight of each of the predefined items in the oncological results as well as the …

18 - 100 years of age Both Phase N/A
A Amaya Olaverri, MD

Thoracic Tumours Register

Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents …

- 100 years of age Both Phase N/A

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.

12 - 100 years of age Both Phase N/A

SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).

18 - 100 years of age Both Phase N/A

A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

This study is a prospective, multicenter non-interventional cohort study designed to develop a registry in unresectable locally advanced or metastatic disease.

18 - 100 years of age Both Phase N/A
P Principal Investigator Selected by Sponsor, M.D., Ph.D.

Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"

Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis

18 - 100 years of age Both Phase N/A

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the …

- 100 years of age Both Phase N/A

Phase-Germ Project: Muscle Mass and Phase Angle in Surgical Patient

Current nutritional diagnostic tools have serious limitations in certain groups of patients such as colon or ovarian cancer with high rates of overweight and obesity in which traditional anthropometric assessment is limited. The objective of the project is to establish a comprehensive nutritional assessment in surgical patients assessed in intensified …

18 - 100 years of age Both Phase N/A
P Paula Dr Jiménez Fonseca, MD-PhD

Spanish Registry of Esophagogastric Cancer

This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach …

18 - 100 years of age Both Phase N/A

Valved Graft PMCF Study

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI